#geron

1 story

#cash reserves #community oncology #fda #imelstat #myelodysplastic #myelofibrosis #nfl #operating expenses #phase 3 #rytelo #telomerase

Geron Targets $240M RYTELO Revenue by 2026
Geron expects $230-240 million in 2026 RYTELO revenue as community adoption grows
Yahoo Finance · 1m